NCT05834023View on ClinicalTrials.gov

Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

December 29, 2023

Study Completion Date

January 5, 2024

Conditions
Pain, AcutePostoperative PainAnalgesia
Interventions
DRUG

Bupivacaine-Lidocaine

Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.25% + Lidocaine 1% + dexamethasone 4 mg + epinephrine 5 mcg/ml

DRUG

Bupivacaine

Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.5% + dexamethasone 4 mg + epinephrine 5 mcg/ml

Trial Locations (1)

Unknown

Hospital de San Carlos Dr. Benicio Arzola Medina, San Carlos

All Listed Sponsors
lead

Hospital de San Carlos Dr. Benicio Arzola Medina

OTHER

NCT05834023 - Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block | Biotech Hunter | Biotech Hunter